AVANIR Pharmaceuticals To paticipate in two conferences in March
ALISO VIEJO, Calif., March 1, 2013
ALISO VIEJO, Calif., March 1, 2013 /PRNewswire/ --Avanir Pharmaceuticals,
Inc. (NASDAQ: AVNR) today announced that company management will present an
overview of the company at the following conferences in March.
oCowen & Company 33^rd Annual Healthcare Conference
oLocation: Boston Marriott Copley Place, Boston, MA
oPresentation date: Tuesday March 5, 2013
oPresentation time: 9:20 a.m. E.T.
o25^th Annual ROTH Conference
oLocation: Ritz-Carlton, Laguna Niguel, CA
oPresentation date: Wednesday March 20, 2013
oPresentation time: 11:30 a.m. P.T.
A live webcast and 30-day archive of these presentations will be available at
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on
bringing innovative medicines to patients with central nervous system
disorders of high unmet medical need. As part of our commitment, we have
extensively invested in our pipeline and are dedicated to advancing medicines
that can substantially improve the lives of patients and their loved ones. For
more information about Avanir, please visit www.avanir.com.
AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc.
in the United States and other countries.
^©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.
Avanir Investor & Media Contact
Ian Clements, PhD
+1 (949) 389-6700
SOURCE Avanir Pharmaceuticals, Inc.
Press spacebar to pause and continue. Press esc to stop.